Radiological, Molecular, and Pathological Factors Unite: A Model for Predicting Recurrence‐Free Survival in Pathological Stage I Lung Adenocarcinoma

Key Points

• To establish and validate a model that predicts recurrence-free survival in patients with pathological stage I lung adenocarcinoma.
• Model integrates radiological, molecular, and pathological factors.
• Validation performed on a cohort of early-stage lung adenocarcinoma patients.
• Assessment of model's discriminatory power for risk classification.
• The model shows excellent discriminatory power for classifying patients' recurrence risk.
• Higher accuracy in predicting recurrence-free survival compared to conventional methods.